Drugs / QUERCETIN-3'-O-PHOSPHATE
QUERCETIN-3'-O-PHOSPHATE
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT01093677 | Mar → Jun 2010 | glucose intolerance | Limerick BioPharma | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT01060475 | Feb → May 2010 | — | Limerick BioPharma | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01364155 | May → Aug 2011 | glucose intolerance | Limerick BioPharma | Unknown | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QUERCETIN-3'-O-PHOSPHATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297397 ↗ |
| Known as | 3'-quercetin phosphate | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297397 ↗ |
| Known as | LIM-0705 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01364155 ↗ |
| Known as | Quercetin 3'-phosphate | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297397 ↗ |
| Modality | Small molecule | — CHEMBL4297397 ↗ |
| Route | Oral | “Oral solution” NCT01060475 ↗ |